Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
3.330
+0.180 (5.71%)
At close: Mar 9, 2026, 4:00 PM EDT
3.340
+0.010 (0.30%)
After-hours: Mar 9, 2026, 7:31 PM EDT
Sana Biotechnology Market Cap
Sana Biotechnology has a market cap or net worth of $888.67 million as of March 9, 2026. Its market cap has increased by 30.07% in one year.
Market Cap
888.67M
Enterprise Value
836.55M
1-Year Change
30.07%
Ranking
Category
Stock Price
$3.33
Market Cap Chart
Since the IPO on February 4, 2021, Sana Biotechnology's market cap has decreased from $1.33B to $888.67M, a decrease of -32.93%. That is a compound annual growth rate of -7.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 840.63M | -22.46% |
| Dec 31, 2025 | 1.08B | 197.89% |
| Dec 31, 2024 | 363.93M | -54.75% |
| Dec 29, 2023 | 804.30M | 7.21% |
| Dec 30, 2022 | 750.19M | -73.52% |
| Dec 31, 2021 | 2.83B | 113.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arbutus Biopharma | 871.23M |
| Arvinas | 869.87M |
| Janux Therapeutics | 841.91M |
| Phathom Pharmaceuticals | 840.78M |
| Evommune | 835.39M |
| BridgeBio Oncology Therapeutics | 833.48M |
| Xencor | 830.19M |
| KalVista Pharmaceuticals | 820.37M |